I am reading all I
have time for regarding Alzheimer’s disease as I have had the unfortunate
opportunity to see this disease on an up-close, personal level. The first thing that struck me when I picked
up this book was the title. I did not
see my loved one’s as strangers. They
were still my father, my mother-in-law and my uncle. They didn’t go anywhere...they were attacked
by a progressive disease that often lasts for many years.
Beyond this
subjective criticism of the book, I would not criticize the emotions felt or
the decision made of anyone who has a loved one subjected to this disease. We all try to do the best we can within the
constraints of our resources. I did find
it interesting that Mr. Gralnick was aggressive and the health system
recommended a mental health facility to “adjust his medication”. There are few resources available for
appropriate treatment of the complicated disease process of Alzheimer’s, but
her description of options tried gives her audience insight into the road
traveled and the hope for a new route in the future.
Despite these observations Comer’s purpose for writing this
book seems not to be to inspire false hope, but to show why Alzheimer’s disease
needs to receive the same level of attention and research funding as other
major diseases—diseases which have seen a decrease in mortality rates while the
incidence of Alzheimer’s disease is rising (one in three people now have
Alzheimer’s disease when they die). A study by researchers at Rand Corporation and other institutions
calculated that the direct cost of care for people with Alzheimer's and other
dementia in 2010 was $109 billion. In comparison, healthcare costs for people
with heart disease was $102 billion; for people with cancer, it was $77
billion. Yet cancer research was allocated an estimated $5.4 billion (2014) in
federal funds, and heart disease will get $1.2 billion — while research on
Alzheimer's and other dementias comes in at only a fraction of that, at $666
million.
For more information regarding research funding see
For more information regarding research funding see
No comments:
Post a Comment